US 9206245
Immunogenic peptides and methods of use for treating and preventing cancer
granted A61KA61K39/0011A61K40/11
Quick answer
US patent 9206245 (Immunogenic peptides and methods of use for treating and preventing cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K39/0011, A61K40/11, A61K40/42, A61P